Cumberland Pharmaceuticals Inc. Stock News

3 penny stocks to buy for under $5 but are they worth the risk? The post Best Penny Stocks To Buy Now? 3 To Watch Under $4 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto

NEW YORK , Nov. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CPIX, T, CRXT, RLX, and NCLH. Full story available on Benzinga.com

Here's three penny stocks to watch with the market down today The post List of Penny Stocks to Watch While The Stock Market is Down Today appeared first on Penny Stocks to Buy, Picks, News and Informa

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-Operative Administration Cumber

The FDA has approved expanded labeling for Cumberland Pharmaceuticals Inc''s (NASDAQ: CPIX ) Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration. The non-narcotic pain reliever can now be administered just before surgery to enable patients to wake up from their procedure in significantly less pain. Supporting Full story available on Benzinga.com

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) rose 117.3% to Full story available on Benzinga.com

Olema Pharmaceuticals (OLMA) stock isn't doing so hot on Tuesday following the release of results from a Phase 1/2 clinical trial. The post OLMA Stock: The Breast Cancer Therapy News That Has Olema Ph

The FDA has approved expanded labeling for Cumberland Pharmaceuticals Inc's (NASDAQ: CPIX) Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative admini

The stock price of Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) increased by over 115% pre-market today. This is why it happened.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 4,000 shares, a decrease of 95.4% from the October 31st total of 87,000 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily []

Cumberland Pharmaceuticals Inc. (CPIX) shares closed 0.9% lower than its previous 52 week low, giving the company a market cap of $33M. The stock is currently down 22.7% year-to-date, down 21.6% over the past 12 months, and down 59.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Trading volume this week was 44.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -32713.4% The company's stock price performance over the past 12 months lags the peer average by -1156.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q3 2021 Results - Earnings Call Transcript

NASHVILLE, Tenn., Sept. 29, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today the national launch of its RediTrex ® (methotrex

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A.J. Kazimi on Q2 2021 Results - Earnings Call Transcript